Table 3.
Comparison of Associations Found Between Candidate Genetic Variants and Serum Etonogestrel Concentrations in the Prior Candidate Gene Study With Etonogestrel Contraceptive Implant Users (n=350)11 With Findings From This Genome-Wide Association Study (n=880, Including 335 From the Prior Study)
| Genetic Variant | Candidate Gene Study Findings | GWAS Study Findings | ||
| β-coefficient* | P | β-coefficient | P | |
| NR1I2 (PXR) rs2461817 | 13.36 | .005 | −0.60 | .84 |
| PGR rs537681 | −29.77 | .007 | 4.5 | .15 |
| CYP3A7*1C | −35.06 | .025 | −26.1 | 8.1×10−3 |
GWAS, genome wide association study.
Calculated using multivariable generalized linear modeling.11